Entrada Therapeutics

IPO

Making Intracellular Therapeutics A Reality

Public · Boston, United States · Founded 2016 · $116.0M raised

Employees
51–200
Founded
2016
Business Model
B2B
Total Funding
$116.0M
Last Round
$116.0M Series BMar 2021
Rounds
2
Type
Public

About

Entrada Therapeutics is driven to discover, develop and commercialize life-changing medicines that are safe, effective and accessible to those who need them. The company treats devastating diseases with intracellular therapeutics, using its proprietary Endosomal Escape Vehicle (EEV) Platform to enable efficient intracellular delivery of a wide range of therapeutics. Its pipeline targets neuromuscular and ocular diseases, including Duchenne muscular dystrophy and myotonic dystrophy type 1, engaging disease-causing targets previously considered inaccessible and undruggable.

Summary

Entrada Therapeutics is a Biotech company based in Boston, United States, founded in 2016. It has raised $116.0M in total across 2 rounds, most recently a $116.0M Series B round in Mar 2021. Investors include Roche.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

IPONov 2021
$208.7M

Sign up to see all 3 rounds

Series A through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Entrada Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/entrada-therapeutics"><img src="https://indexed.vc/api/badge/company/entrada-therapeutics" alt="Entrada Therapeutics on Indexed.vc" width="260" height="76" /></a>